Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Apollomics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APLM.
You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.
Other companies in Apollomics’s space includes: Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM), Palatin Techs (AMEX:PTN), Indaptus Therapeutics (NASDAQ:INDP) and GT Biopharma (NASDAQ:GTBP).
Apollomics has a consensus price target of $8.50.
The stock price for Apollomics (NASDAQ: APLM) is $6.2 last updated May 1, 2025 at 8:55 AM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s FY earnings are confirmed for Thursday, April 3, 2025.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.